TF and atherosclerosis: The inability of CLO to prevent TNFα from inducing TF [71], together with the higher serum TNFα levels seen in CLO treatment (Fig 4D), may have led to greater atherosclerosis in CLO-treated mice than in TIC-treated mice in the current study (Fig 2).